Logo
x

Search category

Subscribe Now

Sanofi

Sanofi Collaborated with Teva to Co-Develop and Co-Commercialize TEV ‘574 for Inflammatory Bowel Disease

Sanofi Collaborated with Teva to Co-Develop and Co-Commercialize TEV ‘574 for Inflammatory Bowel Disease

  • October 4, 2023
Sanofi Entered into an Agreement with Janssen to Develop and Commercialize Vaccine Candidate for Extraintestinal Pathogenic E. Coli

Sanofi Entered into an Agreement with Janssen to Develop and Commercialize Vaccine Candidate for Extraintestinal Pathogenic E. Col...

  • October 3, 2023
Sanofi Receives the MHLW’s Marketing Authorization for Altuviiio to Treat Hemophilia A

Sanofi Receives the MHLW’s Marketing Authorization for Altuviiio to Treat Hemophilia A

  • September 25, 2023
PharmaShots Weekly Snapshots (June 26 – 30, 2023)

PharmaShots Weekly Snapshots (June 26 – 30, 2023)

  • July 1, 2023
Sanofi and SK Bioscience Report Result of GBP410 in P-II Trial to Treat Pneumococcal Diseases in Infants

Sanofi and SK Bioscience Report Result of GBP410 in P-II Trial to Treat Pneumococcal Diseases in Infants

  • June 30, 2023
Sanofi Reports P-IIb Study (STREAM-AD) Results of Amlitelimab for the Treatment of Atopic Dermatitis

Sanofi Reports P-IIb Study (STREAM-AD) Results of Amlitelimab for the Treatment of Atopic Dermatitis

  • June 28, 2023
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2023 PharmaShots - All Rights Reserved.